VHH nanoBiTE™ service


Catalog Number Pack Size List Price* Quantity
nanoBiTE Inquire   Inquire

* CHF, excl. 8.1% VAT and shipping costs


Product Description

Abnova's VHH nanoBiTE™ service focuses on developing bispecific VHH antibodies without an Fc domain, ideal for immune and tumor cell redirecting, multiple epitope targeting, and novel immuno-oncology research. Their smaller molecular size enhances tissue penetration, making them suitable for hard-to-access areas like the tumor microenvironment. The absence of an Fc region prevents unwanted immune activation by avoiding Fc receptor binding, supporting precise mechanistic action. Engineered through the genetic fusion of two VHH domains via a flexible peptide linker, VHH nanoBiTE™ ensures robust antigen binding with reduced production complexity.

Category Custom Service
Supplier Abnova
Regulatory Status RUO
Tech. Data Sheet View datasheet
Link To Supplier https://www.abnova.com
Material Safety Data Sheet Download PDF